Avalon BioVentures I, LP sold $10.1M of Janux Therapeutics (JANX)

Executed Sep 6 2024, disclosed Sep 10 2024, 4 days later.

Value, as filed

$10.1M

240,000 sh across 3 lots

Executed

Sep 6 2024

the trade date, as filed

Disclosed

Sep 10 2024

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

AL Avalon BioVentures I, LP 10% owner profile →

Avalon BioVentures I, LP (10% owner) filed 1 Form 4 report as a reporting entity in the past 24 months (0 purchases, 1 sale), most often in JANX. The largest single filing was $14.2M of JANX (301,649 sh across 9 lots, as filed), executed Sep 26 2024.

The name

JANX JANX JANX · 18 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Avalon BioVentures I, LP in JANX

JANXSALE Janux Therapeutics, Inc. $14.2M
301,649 sh across 9 lots
Exec Sep 26 2024
Filed Sep 30 2024 · 5:30 PM ET JANXSALE Janux Therapeutics, Inc. $21.2M
451,091 sh across 9 lots
Exec Sep 10 2024
Filed Sep 12 2024 · 5:30 PM ET